Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-09-07
DOI
10.1002/jcp.27163
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer
- (2017) T L Mao et al. GENE THERAPY
- Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention
- (2017) Ning Zheng et al. MOLECULAR CARCINOGENESIS
- Enterolactone has stronger effects than enterodiol on ovarian cancer
- (2017) Huidi Liu et al. Journal of Ovarian Research
- MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells
- (2016) Peixin Dong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Myeloid-derived suppressor cells (MDSC) facilitate distant metastasis of malignancies by shielding circulating tumor cells (CTC) from immune surveillance
- (2016) Qiaofei Liu et al. MEDICAL HYPOTHESES
- CXCR4 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma
- (2015) Masakazu Goto et al. ANNALS OF SURGICAL ONCOLOGY
- Effect of the WWOX gene on the regulation of the cell cycle and apoptosis in human ovarian cancer stem cells
- (2015) HONGCHAO YAN et al. Molecular Medicine Reports
- Integrative network analysis for survival-associated gene-gene interactions across multiple genomic profiles in ovarian cancer
- (2015) Hyun-hwan Jeong et al. Journal of Ovarian Research
- CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
- (2015) Urszula M. Domanska et al. NEOPLASIA
- jvenn: an interactive Venn diagram viewer
- (2014) Philippe Bardou et al. BMC BIOINFORMATICS
- CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
- (2014) Margaret Gil et al. JOURNAL OF IMMUNOLOGY
- STRING v10: protein–protein interaction networks, integrated over the tree of life
- (2014) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis
- (2014) Yanan Sun et al. TUMOR BIOLOGY
- Effect of the LPA-mediated CXCL12-CXCR4 axis in the tumor proliferation, migration and invasion of ovarian cancer cell lines
- (2014) HUI WANG et al. Oncology Letters
- High Expression of CXCR4 and CXCR7 Predicts Poor Survival in Gallbladder Cancer
- (2013) X Yao et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Imaging CXCL12-CXCR4 Signaling in Ovarian Cancer Therapy
- (2013) Emma Salomonnson et al. PLoS One
- SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial–mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway
- (2012) Xuqi Li et al. CANCER LETTERS
- Ovarian Cancer
- (2012) JESSICA HUNN et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- A review on CXCR4/CXCL12 axis in oncology: No place to hide
- (2012) Urszula M. Domanska et al. EUROPEAN JOURNAL OF CANCER
- CXCR4 Antagonist AMD3100 Protects Blood–Brain Barrier Integrity and Reduces Inflammatory Response After Focal Ischemia in Mice
- (2012) Jun Huang et al. STROKE
- CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
- (2011) E. Righi et al. CANCER RESEARCH
- Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary
- (2011) Ryuichiro Sekiya et al. HUMAN PATHOLOGY
- Trophoblast-derived chemokine CXCL12 promotes CXCR4 expression and invasion of human first-trimester decidual stromal cells
- (2011) L. Ren et al. HUMAN REPRODUCTION
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Stromal CXCR4 and CXCL12 Expression is Associated with Distant Recurrence and Poor Prognosis in Rectal Cancer After Chemoradiotherapy
- (2010) Susumu Saigusa et al. ANNALS OF SURGICAL ONCOLOGY
- SGO White Paper on Ovarian Cancer: Etiology, Screening and Surveillance
- (2010) John O. Schorge et al. GYNECOLOGIC ONCOLOGY
- Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers
- (2010) Erik De Clercq PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started